AI-generated summary
The authors studied 24 patients with active acne who received four sessions of fractional 1,550-nm erbium glass laser treatment over about two months, with follow-up for one year. They report a significant reduction in lesion counts and in sebaceous gland size after treatment. The study used a split-face design with image analysis.
- Participants
- 24
- Who or what was studied
- Twenty-four patients with active acne lesions
- Limits stated in the abstract
- The abstract does not describe a control group comparison outcome beyond a split-face design, and it reports no information on sample size justification or blinding.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.